These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24252070)

  • 1. Targeted polysaccharide nanoparticle for adamplatin prodrug delivery.
    Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
    J Med Chem; 2013 Dec; 56(23):9725-36. PubMed ID: 24252070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
    Shi Y; Goodisman J; Dabrowiak JC
    Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camptothecin-Polysaccharide Co-assembly and Its Controlled Release.
    Yang Y; Zhang YM; Li D; Sun HL; Fan HX; Liu Y
    Bioconjug Chem; 2016 Dec; 27(12):2834-2838. PubMed ID: 27998070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects.
    Hernández-Gil J; Cobaleda-Siles M; Zabaleta A; Salassa L; Calvo J; Mareque-Rivas JC
    Adv Healthc Mater; 2015 May; 4(7):1034-42. PubMed ID: 25846677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fighting the resistance: rejuvenating anticancer platinum-based drugs.
    O'Hare A
    Nanomedicine (Lond); 2012 Jul; 7(7):947-8. PubMed ID: 23019670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide-based Noncovalent Assembly for Targeted Delivery of Taxol.
    Yang Y; Zhang YM; Chen Y; Chen JT; Liu Y
    Sci Rep; 2016 Jan; 6():19212. PubMed ID: 26759029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
    Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
    Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous amphiphilic P(3HV-co-4HB)-b-mPEG block copolymer synthesized from bacterial copolyester via melt transesterification: nanoparticle preparation, cisplatin-loading for cancer therapy and in vitro evaluation.
    Shah M; Ullah N; Choi MH; Kim MO; Yoon SC
    Eur J Pharm Biopharm; 2012 Apr; 80(3):518-27. PubMed ID: 22178562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox Sensitive Shell and Core Crosslinked Hyaluronic Acid Nanocarriers for Tumor-Targeted Drug Delivery.
    Zheng H; Yin L; Zhang X; Zhang H; Hu R; Yin Y; Qiu T; Xiong X; Wang Q
    J Biomed Nanotechnol; 2016 Aug; 12(8):1641-53. PubMed ID: 29342343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
    Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
    ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin.
    Zhang YM; Cao Y; Yang Y; Chen JT; Liu Y
    Chem Commun (Camb); 2014 Nov; 50(86):13066-9. PubMed ID: 25222700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-responsive fluorescent camptothecin prodrug/polysaccharide supramolecular assembly for targeted cellular imaging and in situ controlled drug release.
    Zhang YH; Zhang YM; Sheng X; Wang J; Liu Y
    Chem Commun (Camb); 2020 Jan; 56(7):1042-1045. PubMed ID: 31868189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
    Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
    Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
    Lundberg BB
    Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
    Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
    J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.